Search Results - Bayer Company Press Release

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA

    Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA by Bayer Company Press Release

    Published 2018-11-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: